Stock Code: 002581
Stock Abbreviation: *ST Shenglu
Announcement No.: 2026-040
Shandong Shenglu Pharmaceutical Co., Ltd.
Announcement on Abnormal Fluctuations in Stock Trading
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or major omissions.
Special Reminder:
Shandong Shenglu Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") disclosed the "Announcement on the Company's Stock Being Subject to Delisting Risk Warning and Suspension" (Announcement No.: 2026-022) on April 29, 2026. The Company's audited total profit, net profit, and net profit after deducting non-recurring gains and losses for 2025 were negative, and its operating income after deduction was less than 300 million yuan. According to Article 9.3.1 of the "Shenzhen Stock Exchange Stock Listing Rules," the Company's stock was subject to a "delisting risk warning" from the opening of trading on April 30, 2026.
I. Situation of Abnormal Stock Trading Fluctuations